Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy

Young Youl Hyun, In Ok Kim, Mi Hyung Kim, Deok Hwa Nam, Mi Hwa Lee, Jung Eun Kim, Hye Kyoung Song, Jin Joo Cha, Young Sun Kang, Ji Eun Lee, Hyun Wook Kim, Jee Young Han, Dae-Ryong Cha

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

T-cell dysregulation plays an important role in the pathogenesis of immunoglobulin A nephropathy (IgAN). Adipose-derived stem cells (ASCs) have been reported to be able to prevent tissue damage through immunemodulating effects. To evaluate the effects of ASCs in high IgA ddY (HIGA) mice, ASCs were isolated from HIGA mice with different stages of IgAN before and after disease onset. ASCs were injected at a dose of 5 × 106 cells/kg body weight through the tail vein every 2 weeks for 3 months. Although the administered ASCs were rarely detected in the glomeruli, 24-h proteinuria was markedly decreased in all ASC-treated groups. Although glomerular deposition of IgA was not significantly different among groups, mesangial proliferation and glomerulosclerosis were dramatically decreased in most ASC treatment groups. In addition, levels of fibrotic and inflammatory molecules were markedly decreased by ASC treatment. Interestingly, ASC therapy significantly decreased Th1 cytokine activity in the kidney and caused a shift to Th2 responses in spleen T-cells as determined by FACS analysis. Furthermore, conditioned media from ASCs abrogated aggregated IgA-induced Th1 cytokine production in cultured HIGA mesangial cells. These results suggest that the beneficial effects of ASC treatment in IgAN occur via paracrine mechanisms that modulate the Th1/Th2 cytokine balance. ASCs are therefore a promising new therapeutic agent for the treatment of IgAN.

Original languageEnglish
Pages (from-to)2425-2439
Number of pages15
JournalCell Transplantation
Volume21
Issue number11
DOIs
Publication statusPublished - 2012 Dec 31

Fingerprint

Stem cells
Immunoglobulin A
Stem Cells
Kidney
IGA Glomerulonephritis
T-cells
Th1-Th2 Balance
Cytokines
T-Lymphocytes
Therapeutics
Mesangial Cells
Conditioned Culture Medium
Cell- and Tissue-Based Therapy
Proteinuria
Tail
Veins
Spleen
Body Weight
Tissue

Keywords

  • Adipose-derived stem cells (ASCs)
  • Glomerulosclerosis
  • HIGA mice
  • Proteinuria
  • Th1 cytokine

ASJC Scopus subject areas

  • Biomedical Engineering
  • Cell Biology
  • Transplantation

Cite this

Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy. / Hyun, Young Youl; Kim, In Ok; Kim, Mi Hyung; Nam, Deok Hwa; Lee, Mi Hwa; Kim, Jung Eun; Song, Hye Kyoung; Cha, Jin Joo; Kang, Young Sun; Lee, Ji Eun; Kim, Hyun Wook; Han, Jee Young; Cha, Dae-Ryong.

In: Cell Transplantation, Vol. 21, No. 11, 31.12.2012, p. 2425-2439.

Research output: Contribution to journalArticle

Hyun, YY, Kim, IO, Kim, MH, Nam, DH, Lee, MH, Kim, JE, Song, HK, Cha, JJ, Kang, YS, Lee, JE, Kim, HW, Han, JY & Cha, D-R 2012, 'Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy', Cell Transplantation, vol. 21, no. 11, pp. 2425-2439. https://doi.org/10.3727/096368912X639008
Hyun, Young Youl ; Kim, In Ok ; Kim, Mi Hyung ; Nam, Deok Hwa ; Lee, Mi Hwa ; Kim, Jung Eun ; Song, Hye Kyoung ; Cha, Jin Joo ; Kang, Young Sun ; Lee, Ji Eun ; Kim, Hyun Wook ; Han, Jee Young ; Cha, Dae-Ryong. / Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy. In: Cell Transplantation. 2012 ; Vol. 21, No. 11. pp. 2425-2439.
@article{04b1080c70be4277a4ee948f66e1363b,
title = "Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy",
abstract = "T-cell dysregulation plays an important role in the pathogenesis of immunoglobulin A nephropathy (IgAN). Adipose-derived stem cells (ASCs) have been reported to be able to prevent tissue damage through immunemodulating effects. To evaluate the effects of ASCs in high IgA ddY (HIGA) mice, ASCs were isolated from HIGA mice with different stages of IgAN before and after disease onset. ASCs were injected at a dose of 5 × 106 cells/kg body weight through the tail vein every 2 weeks for 3 months. Although the administered ASCs were rarely detected in the glomeruli, 24-h proteinuria was markedly decreased in all ASC-treated groups. Although glomerular deposition of IgA was not significantly different among groups, mesangial proliferation and glomerulosclerosis were dramatically decreased in most ASC treatment groups. In addition, levels of fibrotic and inflammatory molecules were markedly decreased by ASC treatment. Interestingly, ASC therapy significantly decreased Th1 cytokine activity in the kidney and caused a shift to Th2 responses in spleen T-cells as determined by FACS analysis. Furthermore, conditioned media from ASCs abrogated aggregated IgA-induced Th1 cytokine production in cultured HIGA mesangial cells. These results suggest that the beneficial effects of ASC treatment in IgAN occur via paracrine mechanisms that modulate the Th1/Th2 cytokine balance. ASCs are therefore a promising new therapeutic agent for the treatment of IgAN.",
keywords = "Adipose-derived stem cells (ASCs), Glomerulosclerosis, HIGA mice, Proteinuria, Th1 cytokine",
author = "Hyun, {Young Youl} and Kim, {In Ok} and Kim, {Mi Hyung} and Nam, {Deok Hwa} and Lee, {Mi Hwa} and Kim, {Jung Eun} and Song, {Hye Kyoung} and Cha, {Jin Joo} and Kang, {Young Sun} and Lee, {Ji Eun} and Kim, {Hyun Wook} and Han, {Jee Young} and Dae-Ryong Cha",
year = "2012",
month = "12",
day = "31",
doi = "10.3727/096368912X639008",
language = "English",
volume = "21",
pages = "2425--2439",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "11",

}

TY - JOUR

T1 - Adipose-derived stem cells improve renal function in a mouse model of IgA nephropathy

AU - Hyun, Young Youl

AU - Kim, In Ok

AU - Kim, Mi Hyung

AU - Nam, Deok Hwa

AU - Lee, Mi Hwa

AU - Kim, Jung Eun

AU - Song, Hye Kyoung

AU - Cha, Jin Joo

AU - Kang, Young Sun

AU - Lee, Ji Eun

AU - Kim, Hyun Wook

AU - Han, Jee Young

AU - Cha, Dae-Ryong

PY - 2012/12/31

Y1 - 2012/12/31

N2 - T-cell dysregulation plays an important role in the pathogenesis of immunoglobulin A nephropathy (IgAN). Adipose-derived stem cells (ASCs) have been reported to be able to prevent tissue damage through immunemodulating effects. To evaluate the effects of ASCs in high IgA ddY (HIGA) mice, ASCs were isolated from HIGA mice with different stages of IgAN before and after disease onset. ASCs were injected at a dose of 5 × 106 cells/kg body weight through the tail vein every 2 weeks for 3 months. Although the administered ASCs were rarely detected in the glomeruli, 24-h proteinuria was markedly decreased in all ASC-treated groups. Although glomerular deposition of IgA was not significantly different among groups, mesangial proliferation and glomerulosclerosis were dramatically decreased in most ASC treatment groups. In addition, levels of fibrotic and inflammatory molecules were markedly decreased by ASC treatment. Interestingly, ASC therapy significantly decreased Th1 cytokine activity in the kidney and caused a shift to Th2 responses in spleen T-cells as determined by FACS analysis. Furthermore, conditioned media from ASCs abrogated aggregated IgA-induced Th1 cytokine production in cultured HIGA mesangial cells. These results suggest that the beneficial effects of ASC treatment in IgAN occur via paracrine mechanisms that modulate the Th1/Th2 cytokine balance. ASCs are therefore a promising new therapeutic agent for the treatment of IgAN.

AB - T-cell dysregulation plays an important role in the pathogenesis of immunoglobulin A nephropathy (IgAN). Adipose-derived stem cells (ASCs) have been reported to be able to prevent tissue damage through immunemodulating effects. To evaluate the effects of ASCs in high IgA ddY (HIGA) mice, ASCs were isolated from HIGA mice with different stages of IgAN before and after disease onset. ASCs were injected at a dose of 5 × 106 cells/kg body weight through the tail vein every 2 weeks for 3 months. Although the administered ASCs were rarely detected in the glomeruli, 24-h proteinuria was markedly decreased in all ASC-treated groups. Although glomerular deposition of IgA was not significantly different among groups, mesangial proliferation and glomerulosclerosis were dramatically decreased in most ASC treatment groups. In addition, levels of fibrotic and inflammatory molecules were markedly decreased by ASC treatment. Interestingly, ASC therapy significantly decreased Th1 cytokine activity in the kidney and caused a shift to Th2 responses in spleen T-cells as determined by FACS analysis. Furthermore, conditioned media from ASCs abrogated aggregated IgA-induced Th1 cytokine production in cultured HIGA mesangial cells. These results suggest that the beneficial effects of ASC treatment in IgAN occur via paracrine mechanisms that modulate the Th1/Th2 cytokine balance. ASCs are therefore a promising new therapeutic agent for the treatment of IgAN.

KW - Adipose-derived stem cells (ASCs)

KW - Glomerulosclerosis

KW - HIGA mice

KW - Proteinuria

KW - Th1 cytokine

UR - http://www.scopus.com/inward/record.url?scp=84871545311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871545311&partnerID=8YFLogxK

U2 - 10.3727/096368912X639008

DO - 10.3727/096368912X639008

M3 - Article

VL - 21

SP - 2425

EP - 2439

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 11

ER -